Traduction de «drive by governments toward » (Néerlandais → Français) :

The diversity of our portfolio and our capacity to innovate across it provides a degree of insulation from dynamics such as the debt crisis and the increasing drive by governments toward healthcare cost containment.
La diversité de notre portefeuille et notre capacité d’innover partout nous met en partie à l'abri des conséquences de la crise de la dette et de la pression exercée par les gouvernements pour contenir les coûts de la santé.

het uitgebreid beleidsdocument: Drink Driving: Towards Zero Tolerance (PDF)
Le document de politique globale: Drink Driving: Towards Zero Tolerance (PDF)

Deliveries for supply contracts with governments around the world for A (H1N1) pandemic flu vaccines and adjuvants generated net sales of USD 1.3 billion, significantly driving the increase over the year-ago period.
Cette augmentation provient en grande partie des contrats de livraison aux gouvernements du monde entier de vaccins et adjuvants contre la pandémie de grippe A(H1N1) dont le chiffre d'affaires net a atteint USD 1,3 milliard.

Deliveries for supply contracts with governments around the world for A(H1N1) pandemic flu vaccines and adjuvants generated net sales of USD 1.3 billion, significantly driving the increase over the year-ago period.
Cette augmentation provient en grande partie des contrats de livraison aux gouvernements du monde entier de vaccins et adjuvants contre la pandémie de grippe A(H1N1) dont le chiffre d'affaires net a atteint USD 1,3 milliard.

The formation of the FAMHP is an important step towards an efficient, modern government service with sufficient management autonomy to respond flexibly to the expectations of the various stakeholders: the users of medicines, healthcare professionals, the pharmaceutical industry and the political authorities at the different levels of competency (European, federal, regional).
The formation of the FAMHP is an important step towards an efficient, modern government service with sufficient management autonomy to respond flexibly to the expectations of the various stakeholders: the users of medicines, healthcare professionals, the pharmaceutical industry and the political authorities at the different levels of competency (European, federal, regional).